Google
Trusted Resources: News & Meetings
Latest announcements and gatherings
He Inherited A Devastating Disease. A CRISPR Gene-Editing Breakthrough Stopped It
Patrick Doherty had always been very active. He trekked the Himalayas and hiked trails in Spain. But about a year and a half ago, he noticed pins and needles in his fingers and toes. His feet got cold. And then he started getting out of breath any time he walked his dog up the hills of County Donegal in Ireland where he lives. “I noticed on some of the larger hill climbs I was getting a bit breathless,” says Doherty, 65. “So I realized something was wrong.”
Doherty found out he had a rare, but devastating inherited disease – known as transthyretin amyloidosis – that had killed his father. A misshapen protein was building up in his body, destroying important tissues, such as nerves in his hands and feet and his heart.
myBinderRelated Content
-
Transthyretin Amyloidosis: Information for Patients and FamilyWhat is transthyretin amyloidosis? Tran...
-
Inotersen Treatment for Patients With Hereditary Transthyretin AmyloidosisBackground: Hereditary transthyretin am...
-
Q&A Discussion on Attralus Trials and Diflunisal Use – ASG Webinar 7.15.23 – 7/7https://www.youtube.com/watch?v=UcxmPgZ7...
-
Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic ReviewImportance: Many patients with systemic ...
-
TTR MutationsSequence Mutations of Human Transthyreti...
-
Intellia and Regeneron Announce Updated Phase 1 Data Demonstrating a Single Dose of NTLA-2001, an Investigational CR...Intellia Therapeutics, Inc. and Regenero...
-
Chafic Karam, MDDr. Chafic Karam is a Neurologist at the...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Community Key Collaborator
Support for this landing page is provided by an independent education grant from
Translation of this platform made possible through an independent education grant from
Powered by
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
